Keywords: Breast, Breast, breast tumor; dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI); Ultrafast Breast MRI
Motivation: Studies of ultrafast dynamic contrast-enhanced (DCE)-MRI were previously focused primarily on differentiating between benign and malignant breast tumors, with little research on lymph node metastases.
Goal(s): We searched for noninvasive biomarkers to predict lymph node metastases in patients with breast cancer using ultrafast DCE-MRI.
Approach: Ultrafast DCE-MRI was performed using a GRASP sequence, and the proprietary kinetic indicators were calculated to quantitatively diagnose lymph node metastases.
Results: The relative peak enhancement of patients with lymph node metastasis was significantly higher than that of those without metastasis (area under the curve: 0.671)
Impact: In this feasibility study, we preliminarily explored the role of ultrafast breast MRI in diagnosing lymph node metastasis in patients with infiltrating ductal carcinoma. We found that relative peak enhancement can be used to predict lymph node metastasis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords